Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients (PANTHER)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00798070 |
Recruitment Status : Unknown
Verified September 2020 by Prof Jonas Bergh, Karolinska University Hospital.
Recruitment status was: Active, not recruiting
First Posted : November 25, 2008
Last Update Posted : September 3, 2020
|
Sponsor:
Karolinska University Hospital
Collaborators:
Swedish Breast Cancer Group
Austrian Breast & Colorectal Cancer Study Group
German Breast Group
Information provided by (Responsible Party):
Prof Jonas Bergh, Karolinska University Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Actual Primary Completion Date : | April 2016 |
Estimated Study Completion Date : | January 2022 |
Publications of Results:
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Other Publications:
Bergh J. Oral presentation, ASCO Annual Meeting 2016.
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):